Graphite Bio, Inc. Contracts & Agreements

67 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sales Agreement between LENZ Therapeutics, Inc. and TD Securities (USA) LLC for Up to $150 Million Common Stock
Equity Distribution Agreements
Graphite Bio, Inc.
Biotechnology
NY
2025
Description of LENZ Therapeutics, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Registration Rights Agreements
Graphite Bio, Inc.
Biotechnology
DE
2025
Stock Purchase Agreement between LENZ Therapeutics, Inc. and Ridgeback Capital Investments L.P. dated July 14, 2024
Stock Agreements
Graphite Bio, Inc.
Biotechnology
NY
2024
Support Agreement among Graphite Bio, Inc., Lenz Therapeutics, Inc., and Certain Stockholders Dated November 14, 2023
Voting Agreements
Graphite Bio, Inc.
Biotechnology
DE
2024
Support Agreement among Graphite Bio, Inc., Lenz Therapeutics, Inc., and Certain Stockholders Dated November 14, 2023
Voting Agreements
Graphite Bio, Inc.
Biotechnology
DE
2024
Lock-Up Agreement between Graphite Bio, Inc. and Shareholder Related to Merger with Lenz Therapeutics, Inc.
Graphite Bio, Inc.
Biotechnology
2024
Lenz Therapeutics, Inc. 2024 Equity Incentive Plan
Equity Distribution Agreements
Graphite Bio, Inc.
Biotechnology
DE
2024
Lenz Therapeutics, Inc. 2024 Employee Stock Purchase Plan
Equity Distribution Agreements
Graphite Bio, Inc.
Biotechnology
DE
2024
Registration Rights Agreement between Graphite Bio, Inc. and Investors (March 21, 2024)
Registration Rights Agreements
Graphite Bio, Inc.
Biotechnology
NY
2024
Amended and Restated Certificate of Incorporation of Lenz Therapeutics, Inc.
Articles of Incorporation
Graphite Bio, Inc.
Biotechnology
DE
2023
Amended and Restated By-Laws of Lenz Therapeutics, Inc.
Operating Agreements
Graphite Bio, Inc.
Biotechnology
2023
Presbyopia Therapies, Inc. Series A Preferred Stock Warrant Agreement (October 30, 2020)
Warrant Agreements
Graphite Bio, Inc.
Biotechnology
DE
2023
Warrant to Purchase Shares of Common Stock between Presbyopia Therapies, Inc. and Nordan Limited Partnership
Warrant Agreements
Graphite Bio, Inc.
Biotechnology
DE
2023
Presbyopia Therapies, Inc. 2020 Equity Incentive Plan
Equity Distribution Agreements
Graphite Bio, Inc.
Biotechnology
DE
2023
LENZ Therapeutics, Inc. Executive Change in Control and Severance Policy
Change of Control Agreements
Graphite Bio, Inc.
Biotechnology
CA
2023
Support Agreement among Graphite Bio, Inc., Lenz Therapeutics, Inc., and Certain Stockholders Dated November 2023
Voting Agreements
Graphite Bio, Inc.
Biotechnology
DE
2023
Support Agreement among Graphite Bio, Inc., Lenz Therapeutics, Inc., and Company Stockholders (November 2023)
Voting Agreements
Graphite Bio, Inc.
Biotechnology
DE
2023
Lock-Up Agreement between Graphite Bio, Inc. and Shareholder Regarding Merger with Lenz Therapeutics, Inc.
Graphite Bio, Inc.
Biotechnology
2023
Graphite Bio, Inc. Subscription Agreement with Purchasers Dated November 14, 2023
Subscription Agreements
Graphite Bio, Inc.
Biotechnology
NY
2023
Description of Registered Securities and Registration Rights of Graphite Bio, Inc.
Registration Rights Agreements
Graphite Bio, Inc.
Biotechnology
DE
2022
Graphite Bio, Inc. Chief Financial Officer Employment Offer Letter to Alethia Young (October 20, 2021)
Employment Agreements
Graphite Bio, Inc.
Biotechnology
CA
2022
Underwriting Agreement between Graphite Bio, Inc. and Underwriters for Common Stock Offering (June 24, 2021)
Underwriting Agreements
Graphite Bio, Inc.
Biotechnology
NY
2021
Underwriting Agreement between Graphite Bio, Inc. and Underwriters (Morgan Stanley, BofA Securities, Cowen, SVB Leerink)
Underwriting Agreements
Graphite Bio, Inc.
Biotechnology
NY
2021
Graphite Bio, Inc. 2021 Employee Stock Purchase Plan
Equity Distribution Agreements
Graphite Bio, Inc.
Biotechnology
DE
2021
Graphite Bio, Inc. Director Indemnification Agreement with [Director Name]
Indemnification Agreements
Graphite Bio, Inc.
Biotechnology
DE
2021
Exclusive License Agreement between Stanford University and Graphite Bio, Inc.
License Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Amendment No. 1 to Exclusive License Agreement between Stanford University and Graphite Bio, Inc.
License Agreements
Graphite Bio, Inc.
Biotechnology
2021
Amendment No. 2 to Exclusive License Agreement between Stanford University and Graphite Bio, Inc.
License Agreements
Graphite Bio, Inc.
Biotechnology
2021
Exclusive Option Agreement between Stanford University and Graphite Bio, Inc.
License Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Exclusive Option Agreement between Stanford University and Graphite Bio, Inc. (April 12, 2021)
License Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Graphite Bio, Inc. Common Stock Certificate
Stock Agreements
Graphite Bio, Inc.
Biotechnology
2021
License Agreement between Integrated DNA Technologies, Inc. and Graphite Bio, Inc. (June 7, 2021)
License Agreements
Graphite Bio, Inc.
Biotechnology
DE
2021
Amended and Restated Investors' Rights Agreement among Graphite Bio, Inc., Investors, and Key Holders (March 11, 2021)
Investor Rights Agreements
Graphite Bio, Inc.
Biotechnology
DE
2021
Executive Offer Letter between Integral Medicines, Inc. and Josh Lehrer (February 28, 2020)
Employment Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Integral Medicines, Inc. Offer Letter to Katherine Stultz for Chief Operating Officer Position
Employment Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Graphite Bio, Inc. Offer Letter to Philip Gutry for Chief Business Officer and Head of Finance and Investor Relations
Employment Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Exclusive License Agreement between Stanford University and Graphite Bio, Inc. (December 7, 2020)
License Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Amendment No. 1 to Exclusive License Agreement between Stanford University and Graphite Bio, Inc.
License Agreements
Graphite Bio, Inc.
Biotechnology
2021
Amendment No. 2 to Exclusive License Agreement between Stanford University and Graphite Bio, Inc.
License Agreements
Graphite Bio, Inc.
Biotechnology
2021
Exclusive Option Agreement between Stanford University and Graphite Bio, Inc.
License Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Exclusive Option Agreement between Stanford University and Graphite Bio, Inc.
Graphite Bio, Inc.
Biotechnology
CA
2021
Advisor Agreement between Integral Medicines, Inc. and Matthew Porteus
Advisory Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Advisor Agreement between Integral Medicines, Inc. and Maria Grazia Roncarolo dated March 26, 2020
Advisory Agreements
Graphite Bio, Inc.
Biotechnology
CA
2021
Confirmatory Employment Letter between LENZ Therapeutics, Inc. and Evert Schimmelpennink
Employment Agreements
Graphite Bio, Inc.
Biotechnology
2024
Confirmatory Employment Letter between LENZ Therapeutics, Inc. and Marc Odrich
Employment Agreements
Graphite Bio, Inc.
Biotechnology
2024
Confirmatory Employment Letter between LENZ Therapeutics, Inc. and Shawn Olsson (March 21, 2024)
Employment Agreements
Graphite Bio, Inc.
Biotechnology
2024
LENZ Therapeutics, Inc. Employment Letter Agreement with Dan Chevallard (Chief Financial Officer)
Employment Agreements
Graphite Bio, Inc.
Biotechnology
2024
Lenz Therapeutics, Inc. Outside Director Compensation Policy
Compensation Agreements
Graphite Bio, Inc.
Biotechnology
2024
Graphite Bio, Inc. Compensation Recovery Policy (Adopted November 14, 2023)
Compensation Agreements
Graphite Bio, Inc.
Biotechnology
2024
Office Lease Agreement between Hankey Investment Company, L.P. and Lenz Therapeutics, Inc. for 445 Marine View Avenue, Suite 320, Del Mar, CA
Lease Agreements
Graphite Bio, Inc.
Biotechnology
2023
Confirmatory Employment Letter between LENZ Therapeutics, Inc. and Evert Schimmelpennink
Employment Agreements
Graphite Bio, Inc.
Biotechnology
2023
Confirmatory Employment Letter between LENZ Therapeutics, Inc. and Shawn Olsson (2024)
Employment Agreements
Graphite Bio, Inc.
Biotechnology
2023
Confirmatory Employment Letter between LENZ Therapeutics, Inc. and Marc Odrich (2024)
Employment Agreements
Graphite Bio, Inc.
Biotechnology
2023
Lenz Therapeutics, Inc. Outside Director Compensation Policy
Compensation Agreements
Graphite Bio, Inc.
Biotechnology
2023
LENZ Therapeutics, Inc. Employee Incentive Compensation Plan
Bonus & Incentive Agreements
Graphite Bio, Inc.
Biotechnology
CA
2023
Agreement and Plan of Merger among Graphite Bio, Inc., Generate Merger Sub, Inc., and Lenz Therapeutics, Inc. (November 14, 2023)
Merger Agreements
Graphite Bio, Inc.
Biotechnology
DE
2023
Graphite Bio, Inc. Chief Executive Officer Employment Offer Letter to Kim Drapkin
Employment Agreements
Graphite Bio, Inc.
Biotechnology
MA
2023
Separation Agreement and Release between Graphite Bio, Inc. and Josh Lehrer
Separation Agreements
Graphite Bio, Inc.
Biotechnology
CA
2023
Sublease Agreement between Graphite Bio, Inc. and Soleil Labs, LLC dated October 26, 2023
Lease Agreements
Graphite Bio, Inc.
Biotechnology
CA
2023
First Amendment to Lease Agreement between Bayside Area Development, LLC and Graphite Bio, Inc.
Lease Agreements
Graphite Bio, Inc.
Biotechnology
CA
2023
Graphite Bio, Inc. 2021 Stock Option and Incentive Plan
Bonus & Incentive Agreements
Graphite Bio, Inc.
Biotechnology
DE
2021
Graphite Bio, Inc. Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Graphite Bio, Inc.
Biotechnology
2021
Graphite Bio, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Graphite Bio, Inc.
Biotechnology
2021
Graphite Bio, Inc. Executive Severance Plan
Severance Agreements
Graphite Bio, Inc.
Biotechnology
DE
2021
Graphite Bio, Inc. 2020 Stock Option and Grant Plan
Bonus & Incentive Agreements
Graphite Bio, Inc.
Biotechnology
DE
2021
Lease Agreement between ARE-San Francisco No. 12, LLC and Integral Medicines, Inc. for 279 East Grand Avenue, South San Francisco
Lease Agreements
Graphite Bio, Inc.
Biotechnology
2021
Lease Agreement between ARE-San Francisco No. 65, LLC and Graphite Bio, Inc. for 201 Haskins Way, South San Francisco
Lease Agreements
Graphite Bio, Inc.
Biotechnology
2021